Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001615774-16-006033
Filing Date
2016-06-22
Accepted
2016-06-22 17:10:59
Documents
1
Effectiveness Date
2016-06-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7590
  Complete submission text file 0001615774-16-006033.txt   8648
Mailing Address 50 W. BROADWAY 3RD FLOOR SALT LAKE CITY X1 84101
Business Address 50 W. BROADWAY 3RD FLOOR SALT LAKE CITY X1 84101 9493465822
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: D | Act: 33 | File No.: 021-265608 | Film No.: 161727143